Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
09:00-09:15 | 09:00-09:15 |
Progress on Antithrombotic Therapy after PCI |
Hongbing Yan | |
09:15-09:18 | 09:15-09:18 |
Discussion |
||
09:18-09:33 | 09:18-09:33 |
Optimized Hypoglycemic Regimen for Patients with Coronary Artery Disease and Diabetes |
Shi Chen | |
09:33-09:36 | 09:33-09:36 |
Discussion |
||
09:36-09:51 | 09:36-09:51 |
Antiplatelet Strategy for CAD Patients with Platelet Abnormalities after PCI |
Lan Huang | Xinqiao Hospital, Army Medical University |
09:51-09:54 | 09:51-09:54 |
Discussion |
||
09:54-10:09 | 09:54-10:09 |
SGLT2i and CAD: from Bench to Bedside |
Kai Huang | Union Hospital of Huazhong University of Science and Technology |
10:09-10:12 | 10:09-10:12 |
Discussion |
||
10:12-10:27 | 10:12-10:27 |
From Successful PCI to the Treatment, the Integrated Optimized Lipid-lowering Strategy for ACS Patients |
Yan Li | Tangdu Hospital, Air Force Medical University |
10:27-10:30 | 10:27-10:30 |
Discussion |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
10:30-10:45 | 10:30-10:45 |
Clinical Application of Platelet Function and Gene Testing |
Yida Tang | Peking University Third Hospital |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
11:00-11:15 | 11:00-11:15 |
Lipoprotein (a) and Primary Prevention of Coronary Heart Disease |
Shuiping Zhao | The Second Xiangya Hospital of Central South University |
11:15-11:22 | 11:15-11:22 |
Discussion |
||
11:22-11:37 | 11:22-11:37 |
Interpretation of Chinese Expert Consensus on the Management of Blood Lipids in Very-High-Risk ASCVD Patients |
Zuyi Yuan | The First Affiliated Hospital of Xi ' An Jiaotong University |
11:37-11:44 | 11:37-11:44 |
Discussion |
||
11:44-11:59 | 11:44-11:59 |
Current Status and Prospects of Clinical Research on New Lipid-Lowering Target Lp(A) |
Daqing Zhang | Shengjinng Hospital of China Medical University |
11:59-12:06 | 11:59-12:06 |
Discussion |
||
12:06-12:21 | 12:06-12:21 |
Interpretation of 2019 CCEP Expert Consensus on Lipid Management |
Yitong Ma | The First Affiliated Hospital of Xinjiang Medical University |
12:21-12:30 | 12:21-12:30 |
Discussion |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
14:00-14:15 | 14:00-14:15 |
Perspective of Initial Combination Therapy from New Progress on Lipids-Lowering Studies |
Hongwei Li | Beijing Friendship Hospital, Capital Medical University |
14:15-14:30 | 14:15-14:30 |
Interpretation of 2019 CCEP Chinese Experts Consensus |
Jianjun Li | Fuwai Hospital, Chinese Academy of Medical Sciences |
14:30-14:45 | 14:30-14:45 |
Developmental Progress of Novel Lipid-Regulating Drugs |
Ping Ye | The Second Medical Center of PLA General Hospital |
14:45-15:00 | 14:45-15:00 |
Combined Lipid-Lowering Therapy, the General Trend |
Zaixin Yu | Xiangya Hospital Central South University |
15:00-15:30 | 15:00-15:30 |
Discussion |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
16:00-16:20 | 16:00-16:20 |
Omega-3 Polyunsaturated Fatty Acids (Fish Oil) and Cardiovascular Disease Prevention |
Guoping Lu | Ruijin Hospital, Shanghai Jiaotong University School of Medicine |
16:20-16:40 | 16:20-16:40 |
Management of Dyslipidemia with Triglyceride-rich Lipoprotein as the Target |
Ping Ye | The Second Medical Center of PLA General Hospital |
16:40-16:45 | 16:40-16:45 |
Discussion |
||
16:45-17:00 | 16:45-17:00 |
Interpretation of Expert Consensus on Antithrombotic Management of Patients with Atrial Fibrillation and Coronary Artery Disease |
Shulin Wu | Guangdong Provincial People's Hospital |
17:00-17:05 | 17:00-17:05 |
Discussion |
||
17:05-17:20 | 17:05-17:20 |
PCSK9 Inhibitor and Acute Coronary Syndrome |
Lingqiu Kong | Affiliated Hospital of Chengdu University of Traditional Chinese Medicine |
17:20-17:30 | 17:20-17:30 |
Discussion |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
19:00-19:15 | 19:00-19:15 |
Clinical Characteristics and Prognostic Analysis of Patients with Coronary Artery Disease and Malignant Tumors |
Yunlong Xia | The First Affiliated Hospital of Dalian Medical University |
19:15-19:23 | 19:15-19:23 |
Discussion |
||
19:23-19:38 | 19:23-19:38 |
Tumor Radio-Therapy and CAD |
Weiyi Fang | |
19:38-19:46 | 19:38-19:46 |
Discussion |
||
19:46-20:01 | 19:46-20:01 |
The PCI Strategy for Patients with Coronary Artery Disease and Tumor |
Hengjian Hao | Xuanwu Hospital Capital Medical University |
20:01-20:09 | 20:01-20:09 |
Discussion |
||
20:09-20:24 | 20:09-20:24 |
Tumor Chemo-Therapy/Targeted Therapy and CAD |
Yundai Chen | The First Medical Center of Chinese PLA General Hospital |
20:24-20:32 | 20:24-20:32 |
Discussion |
||
20:32-20:47 | 20:32-20:47 |
Cancer Complicated with Coronary Artery Disease: View from an Oncologist |
Jing Chen | |
20:47-20:55 | 20:47-20:55 |
Discussion |